Why the study?
The study sought to assess the impact of previous angina symptoms on real-world clinical outcomes in patients with STEMI who underwent successful PCI using DES.
Does previous angina improve clinical outcomes in STEMI patients undergoing PCI with drug-eluting stents?
Does previous angina improve clinical outcomes in STEMI patients undergoing PCI with drug-eluting stents?
Answers are grounded in this paper and cite their sources.
A history of previous angina is associated with a significantly lower risk of major adverse cardiac and cerebrovascular events in STEMI patients undergoing PCI with drug-eluting stents, suggesting a cardioprotective ischemic preconditioning effect.
The present study sought to assess the impact of previous angina symptoms on real world clinical outcomes in patients with ST-elevation myocardial infarction (STEMI) who had undergone successful percutaneous coronary interventions using drug-eluting stents (DES). Patients were selected from 13,650 consecutive patients enrolled in the Korea Acute Myocardial Infarction-National Institute of Health (KAMIR-NIH) registry. A total of 5167 STEMI patients were divided into a previous-angina group (n=1129) and a control group (n=4038). Major adverse cardiac and cerebrovascular events (MACCEs) that included all-cause death, recurrent myocardial infarction (re-MI), repeat PCI, coronary artery bypass graft (CABG), cerebrovascular accident (CVA). Among the 5167 patients with STEMI, MACCEs had occurred in 168 patients in the previous-angina group (14.9%) and 726 patients in the control group (18.0%) (HR, 0.76, 95% CI, 0.60-0.96, p=0.019) at the two-year (800-day) for clinical outcomes. Previous angina was associated with better clinical outcomes with respect to all-cause death (HR, 0.65, 95% CI, 0.44-0.96, p=0.029) and cardiac death (HR, 0.52, 95% CI, 0.31-0.84, p=0.008). Previous angina was a negative risk factor for adverse cardiac events. A previous history of angina predisposes a patient to a favorable outcome after acute myocardial infarction (AMI) in patients with DES implantation.
No takes yet. Share an insight, caveat, or question.
Han et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: